Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)

Conditions:   Cervical Cancer;   Vulvar Cancer;   Vaginal Cancer;   Genital Warts;   Human Papillomavirus InfectionInterventions:   Biological: Comparator: V505 formulation 1;   Drug: Comparator: V505 formulation 2;   Drug: Comparator: V505 formulation 2;   Biological: Comparator: V505 formulation 3;   Biological: Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant;   Biological: Comparator: Placebo (unspecified)Sponsor:   Merck Sharp & Dohme Corp.Completed - verified December 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials